mCRPC (Metastatic Castration-resistant Prostate Cancer) trials recruiting in Illinois

Fewer than 3 recruiting trials found.

All mCRPC (Metastatic Castration-resistant Prostate Cancer) trials nationally

Cities in Illinois

Recruiting trials in Illinois

• A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
  NCT06785636 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · Illinois: Chicago
• Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
  NCT05283330 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago